DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain

Molecular Biology of the Cell

Volumn 20, Issue 20, 2009, Pages 4400-4411

  Erlmann, Patrik ^a   Schmid, Simone ^a   Horenkamp, Florian A ^b   Geyer, Matthias ^b   Pomorski, Thomas G ^c   Olayioye, Monilola A ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN DELETED IN LIVER CANCER 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AMINO ACIDS; CELL LINE; CONSERVED SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GUANOSINE TRIPHOSPHATE; HUMANS; MEMBRANE LIPIDS; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RHOA GTP-BINDING PROTEIN; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 70350105615     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-03-0247     Document Type: Article

References (48)

1. Alpy, F., and Tomasetto, C. (2005). Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J. Cell Sci. 118, 2791-2801. (Pubitemid 41136357)
2. Bernards, A., and Settleman, J. (2005). GAPs in growth factor signalling. Growth Factors 23, 143-149.
3. Bos, J. L., Rehmann, H., and Wittinghofer, A. (2007). GEFs and GAPs: critical elements in the control of small G proteins. Cell 129, 865-877. (Pubitemid 46802708)
4. Brown, M. T., Andrade, J., Radhakrishna, H., Donaldson, J. G., Cooper, J. A., and Randazzo, P. A. (1998). ASAP1, a phospholipid-dependent arf GTPase-activating protein that associates with and is phosphorylated by Src. Mol. Cell. Biol. 18, 7038-7051.
5. Ching, Y. P., Wong, C. M., Chan, S. F., Leung, T. H., Ng, D. C., Jin, D. Y., and Ng, I. O. (2003). Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J. Biol. Chem. 278, 10824-10830.
6. Durkin, M. E., Ullmannova, V., Guan, M., and Popescu, N. C. (2007a). Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth. Oncogene 26, 4580-4589. (Pubitemid 47037045)
7. Durkin, M. E., Yuan, B. Z., Zhou, X., Zimonjic, D. B., Lowy, D. R., Thorgeirsson, S. S., and Popescu, N. C. (2007b). DLC-1, a Rho GTPase-activating protein and tumour suppressor. J. Cell Mol. Med. 11, 1185-1207.
8. Fivaz, M., and Meyer, T. (2003). Specific localization and timing in neuronal signal transduction mediated by protein-lipid interactions. Neuron 40, 319-330. (Pubitemid 37244098)
9. Goodison, S., Yuan, J., Sloan, D., Kim, R., Li, C., Popescu, N. C., and Urquidi, V. (2005). The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 65, 6042-6053. (Pubitemid 40994388)
10. Gureasko, J., Galush, W. J., Boykevisch, S., Sondermann, H., Bar-Sagi, D., Groves, J. T., and Kuriyan, J. (2008). Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat. Struct. Mol. Biol. 15, 452-461.
11. Healy, K. D., Hodgson, L., Kim, T. Y., Shutes, A., Maddileti, S., Juliano, R. L., Hahn, K. M., Harden, T. K., Bang, Y. J., and Der, C. J. (2008). DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol. Carcinog. 47, 326-337.
12. Heering, J., Erlmann, P., and Olayioye, M. A. (2009). Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration. Exp. Cell Res. 315, 2505-2514.
13. Heo, W. D., Inoue, T., Park, W. S., Kim, M. L., Park, B. O., Wandless, T. J., and Meyer, T. (2006). PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science 314, 1458-1461.
14. Holeiter, G., Heering, J., Erlmann, P., Schmid, S., Jahne, R., and Olayioye, M. A. (2008). Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway. Cancer Res. 68, 8743-8751.
15. Homma, Y., and Emori, Y. (1995). A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. EMBO J. 14, 286-291.
16. Hurley, J. H. (2006). Membrane binding domains. Biochim. Biophys. Acta 1761, 805-811.
17. Jackson, T. R., Brown, F. D., Nie, Z., Miura, K., Foroni, L., Sun, J ., Hsu, V. W., Donaldson, J. G., and Randazzo, P. A. (2000). ACAPs are arf6 GTPase-activating proteins that function in the cell periphery. J. Cell Biol. 151, 627-638. (Pubitemid 30828141)
18. Jaffe, A. B., and Hall, A. (2005). Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247-269.
19. Janmey, P. A., and Lindberg, U. (2004). Cytoskeletal regulation: rich in lipids. Nat. Rev. Mol. Cell. Biol. 5, 658-666.
20. Kim, C. A., and Bowie, J. U. (2003). SAM domains: uniform structure, diversity of function. Trends Biochem. Sci. 28, 625-628.
21. Kim, T. Y., Healy, K. D., Der, C. J., Sciaky, N., Bang, Y. J., and Juliano, R. L. (2008). Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration. J. Biol. Chem. 283, 32762-32770.
22. Krugmann, S., et al. (2002). Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 9, 95-108. (Pubitemid 34127774)
23. Lahoz, A., and Hall, A. (2008). DLC1, a significant GAP in the cancer genome. Genes Dev. 22, 1724-1730. (Pubitemid 351915495)
24. Liao, Y. C., Si, L., DeVere White, R. W., and Lo, S. H. (2007). The phosphotyrosine- independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J. Cell Biol. 176, 43-49. (Pubitemid 46041679)
25. Ligeti, E., Dagher, M. C., Hernandez, S. E., Koleske, A. J., and Settleman, J. (2004). Phospholipids can switch the GTPase substrate preference of a GTPase- activating protein. J. Biol. Chem. 279, 5055-5058.
26. Ling, K., Schill, N. J., Wagoner, M. P., Sun, Y., and Anderson, R. A. (2006). Movin' on up: the role of PtdIns(4,5)P(2) in cell migration. Trends Cell Biol. 16, 276-284.
27. Miura, K., Jacques, K. M., Stauffer, S., Kubosaki, A., Zhu, K., Hirsch, D. S., Resau, J., Zheng, Y., and Randazzo, P. A. (2002). ARAP1, a point of convergence for Arf and Rho signaling. Mol. Cell 9, 109-119. (Pubitemid 34127775)
28. Ng, I.O., Liang, Z. D., Cao, L., and Lee, T. K. (2000). DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res. 60, 6581-6584.
29. Oude Weernink, P. A., Schmidt, M., and Jakobs, K. H. (2004). Regulation and cellular roles of phosphoinositide 5-kinases. Eur. J. Pharmacol. 500, 87-99.
30. Papayannopoulos, V., Co, C., Prehoda, K. E., Snapper, S., Taunton, J., and Lim, W. A. (2005). A polybasic motif allows N-WASP to act as a sensor of PIP(2) density. Mol. Cell 17, 181-191.
31. Qian, X., Li, G., Asmussen, H. K., Asnaghi, L., Vass, W. C., Braverman, R., Yamada, K. M., Popescu, N. C., Papageorge, A. G., and Lowy, D. R. (2007). Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc. Natl. Acad. Sci. USA 104, 9012-9017.
32. Ridley, A. J. (2006). Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16, 522-529.
33. Saito, K., Fujimura-Kamada, K., Hanamatsu, H., Kato, U., Umeda, M., Kozminski, K. G., and Tanaka, K. (2007). Transbilayer phospholipid flipping regulates Cdc42p signaling during polarized cell growth via Rga GTPase-activating proteins. Dev. Cell 13, 743-751. (Pubitemid 350011986)
34. Scholz, R. P., Regner, J., Theil, A., Erlmann, P., Holeiter, G., Jahne, R., Schmid, S., Hausser, A., and Olayioye, M. A. (2009). DLC1 interacts with 14-3--3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling. J. Cell Sci. 122, 92-102.
35. Sekimata, M., Kabuyama, Y., Emori, Y., and Homma, Y. (1999). Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J. Biol. Chem. 274, 17757-17762.
36. Takahashi, S., and Pryciak, P. M. (2007). Identification of novel membrane-binding domains in multiple yeast Cdc42 effectors. Mol. Biol. Cell 18, 4945-4956.
37. Wheeler, A. P., and Ridley, A. J. (2004). Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp. Cell Res. 301, 43-49.
38. Williams, C. L. (2003). The polybasic region of Ras and Rho family small GTPases: a regulator of protein interactions and membrane association and a site of nuclear localization signal sequences. Cell Signal. 15, 1071-1080.
39. Wong, C. M., Lee, J. M., Ching, Y. P., Jin, D. Y., and Ng, I. O. (2003). Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 63, 7646-7651. (Pubitemid 37466690)
40. Wong, C. M., Yam, J. W., Ching, Y. P., Yau, T. O., Leung, T. H., Jin, D. Y., and Ng, I. O. (2005). Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res. 65, 8861-8868.
41. Xue, W., et al. (2008). DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 22, 1439-1444. (Pubitemid 351793078)
42. Yam, J. W., Ko, F. C., Chan, C. Y., Jin, D. Y., and Ng, I. O. (2006). Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res. 66, 8367-8372.
43. Yang, X. Y., Guan, M., Vigil, D., Der, C. J., Lowy, D. R., and Popescu, N. C. (2009). p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities. Oncogene.
44. Yoshizaki, H., Ohba, Y., Kurokawa, K., Itoh, R. E., Nakamura, T., Mochizuki, N., Nagashima, K., and Matsuda, M. (2003). Activity of Rho-family GTPases during cell division as visualized with FRET-based probes. J. Cell Biol. 162, 223-232. (Pubitemid 36928836)
45. Yuan, B. Z., Jefferson, A. M., Baldwin, K. T., Thorgeirsson, S. S., Popescu, N. C., and Reynolds, S. H. (2004). DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23, 1405-1411. (Pubitemid 38406835)
46. Yuan, B. Z., Zhou, X., Durkin, M. E., Zimonjic, D. B., Gumundsdottir, K., Eyfjord, J. E., Thorgeirsson, S. S., and Popescu, N. C. (2003). DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 22, 445-450. (Pubitemid 36194340)
47. Zhong, D., Zhang, J., Yang, S., Soh, U. J., Buschdorf, J. P., Zhou, Y. T., Yang, D., and Low, B. C. (2009). The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration. J. Cell Sci. 122, 414-424.
48. Zhou, X., Thorgeirsson, S. S., and Popescu, N. C. (2004). Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 23, 1308-1313. (Pubitemid 38297186)